UNSPSC 85361701: Diagnosis of recurrent and persistent haematuria, minor glomerular abnormality

This classification denotes the group of activities that yields a diagnosis of Recurrent and persistent haematuria on the minor glomerular abnormality. Recurrent and persistent haematuria on the minor glomerular abnormality is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code N02. 0

UNSPSC 85361701 Diagnosis of recurrent and persistent haematuria, minor glomerular abnormality is a Commodity code with minimal alignment to recent state and local procurement activity. The code nominally describes a clinical diagnostic service category, but the three most recent opportunities posted under this code span diagnostic imaging systems infrastructure (a PACS platform), special education contracted services, and temporary health professional staffing — none of which substantively match the code's stated scope of hematuria and glomerular abnormality diagnosis. The mismatch suggests either miscoding at source or a systematic classification drift in how this code is being applied in practice.

The three recent opportunities originate from San Mateo County (California), Birdville Independent School District (Tarrant County, Texas), and Santa Clara County (California). Only the San Mateo Medical Center solicitation (#660002526251, RFP, due October 21, 2026) involves diagnostic imaging and clinical work; it seeks a PACS implementation with EPIC integration supporting radiology, cardiology, and dental imaging across approximately 78,000 annual studies. The other two — Birdville's special education staffing (RFP, due October 21, 2026) and Santa Clara's temporary health professional staffing pool (RFQ, due October 7, 2026) — are education and administrative staffing in scope. The code shows no clustering of relevant clinical-diagnostic opportunities and presents no clear pattern of repeat buying or geographic concentration. For firms targeting genuine diagnostic laboratory or clinical evaluation work, this code warrants rechecking against the actual commodity classifications in use by California and Texas purchasers.